Clearside Biomedical Inc (CLSD)
1.02
-0.03
(-2.86%)
USD |
NASDAQ |
Nov 21, 16:00
1.03
+0.01
(+0.98%)
After-Hours: 20:00
Clearside Biomedical Max Drawdown (5Y): 95.91% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 95.91% |
September 30, 2024 | 97.07% |
August 31, 2024 | 97.63% |
July 31, 2024 | 97.63% |
June 30, 2024 | 97.63% |
May 31, 2024 | 97.63% |
April 30, 2024 | 97.63% |
March 31, 2024 | 97.63% |
February 29, 2024 | 97.63% |
January 31, 2024 | 97.63% |
December 31, 2023 | 97.63% |
November 30, 2023 | 97.63% |
October 31, 2023 | 97.63% |
September 30, 2023 | 97.63% |
August 31, 2023 | 97.63% |
July 31, 2023 | 97.63% |
June 30, 2023 | 97.63% |
May 31, 2023 | 97.63% |
April 30, 2023 | 97.63% |
March 31, 2023 | 97.63% |
February 28, 2023 | 97.63% |
January 31, 2023 | 97.63% |
December 31, 2022 | 97.63% |
November 30, 2022 | 97.63% |
October 31, 2022 | 97.63% |
Date | Value |
---|---|
September 30, 2022 | 97.63% |
August 31, 2022 | 97.63% |
July 31, 2022 | 97.63% |
June 30, 2022 | 97.63% |
May 31, 2022 | 97.63% |
April 30, 2022 | 97.63% |
March 31, 2022 | 97.63% |
February 28, 2022 | 97.63% |
January 31, 2022 | 97.63% |
December 31, 2021 | 97.63% |
November 30, 2021 | 97.63% |
October 31, 2021 | 97.63% |
September 30, 2021 | 97.63% |
August 31, 2021 | 97.63% |
July 31, 2021 | 97.63% |
June 30, 2021 | 97.63% |
May 31, 2021 | 97.63% |
April 30, 2021 | 97.63% |
March 31, 2021 | 97.63% |
February 28, 2021 | 97.63% |
January 31, 2021 | 97.63% |
December 31, 2020 | 97.63% |
November 30, 2020 | 97.63% |
October 31, 2020 | 97.63% |
September 30, 2020 | 97.63% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
95.91%
Minimum
Oct 2024
97.63%
Maximum
Nov 2019
97.59%
Average
97.63%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
Perspective Therapeutics Inc | 91.70% |
Viking Therapeutics Inc | 89.26% |
Atara Biotherapeutics Inc | 99.47% |
Corvus Pharmaceuticals Inc | 95.82% |
Crinetics Pharmaceuticals Inc | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -36.57 |
Beta (5Y) | 2.330 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 91.18% |
Historical Sharpe Ratio (5Y) | -0.0713 |
Historical Sortino (5Y) | -0.1832 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.80% |